An image of induced pluripotent stem cells or iPSCs.
Imagine if you could take a small sample of cells from a person, say some skin or blood cells, and through the wizardry of molecular biology, transform them into stem cells. Stems cells have the capacity of being transformed into any cells in the body, such as heart cells or brain cells. Well, what was science fiction only a decade ago is now science fact. Drs. Shinya Yamanaka and John Gurdon received the Nobel Prize in 2012 for discovering how to "deprogram" skin cells into what are now called Induced Pluripotent Stem Cells or iPSCs.
AUTISM BRAINNET PARTNERSHIPS IMPROVE UNDERSTANDING OF ASD
The Icahn School of Medicine at Mount Sinai (ISMMS), a node of Autism BrainNet and Unyts, the designated organ procurement organization for the eight counties of western New York State, have signed a new agreement that will help increase and enhance the quantity of postmortem brain tissue available for critical autism research.
As the director of the Center for Autism Research and Treatment at UCLA and a distinguished professor in neurology, psychiatry and human genetics at the UCLA School of Medicine, Dan Geschwind is well known for his discoveries and contributions to the field of autism. Since he joined the UCLA faculty in 1997, he has dedicated his time to understanding the neurobiology and genetics. Recent research under his direction has also focused on ensuring that autism research includes more diverse participants, particularly those from different racial and ethnic backgrounds.
On December 7th, 10AM PST and 1PM EST, Dr. Cyndi Schumann from the University of California Davis, will describe how one brain has made a difference in understanding autism by contributing to over 30 research projects. The webinar is free, but registration is required.